Literature DB >> 18195237

Reversible cystoid macular edema secondary to fingolimod in a renal transplant recipient.

Georges Saab, Arghavan Almony, Kevin J Blinder, Rebecca Schuessler, Daniel C Brennan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18195237     DOI： 10.1001/archophthalmol.2007.23

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN： 0003-9950


× No keyword cloud information.
  13 in total

1.  Microcystic macular oedema in multiple sclerosis is associated with disease severity.

Authors:  Jeffrey M Gelfand; Rachel Nolan; Daniel M Schwartz; Jennifer Graves; Ari J Green
Journal:  Brain       Date:  2012-04-25       Impact factor: 13.501

Review 2.  Managing MS in a changing treatment landscape.

Authors:  Martin Duddy; Aiden Haghikia; Eleonora Cocco; Christian Eggers; Jelena Drulovic; Olga Carmona; Helene Zéphir; Ralf Gold
Journal:  J Neurol       Date:  2011-03-25       Impact factor: 4.849

3.  Postoperative cystoid macular oedema in a patient on fingolimod.

Authors:  Jennifer Chen-Chia Fan Gaskin; Michael Coote
Journal:  BMJ Case Rep       Date:  2015-05-12

4.  Does fingolimod in multiple sclerosis patients cause macular edema?

Authors:  Kiran Turaka; Joseph Shepard Bryan
Journal:  J Neurol       Date:  2012-01-10       Impact factor: 4.849

Review 5.  Fingolimod is a potential novel therapy for multiple sclerosis.

Authors:  Orhan Aktas; Patrick Küry; Bernd Kieseier; Hans-Peter Hartung
Journal:  Nat Rev Neurol       Date:  2010-06-15       Impact factor: 42.937

Review 6.  Drug-induced macular edema.

Authors:  Olga E Makri; Ilias Georgalas; Constantine D Georgakopoulos
Journal:  Drugs       Date:  2013-06       Impact factor: 9.546

Review 7.  Fingolimod: therapeutic mechanisms and ocular adverse effects.

Authors:  P Mandal; A Gupta; W Fusi-Rubiano; P A Keane; Y Yang
Journal:  Eye (Lond)       Date:  2016-11-25       Impact factor: 3.775

8.  Early bilateral cystoid macular oedema secondary to fingolimod in multiple sclerosis.

Authors:  Lei Liu; Fiona Cuthbertson
Journal:  Case Rep Med       Date:  2012-09-13

9.  Use of a biomarker in exposure-response analysis to support dose selection for fingolimod.

Authors:  J-Y Lee; Y Wang
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2013-08-21

10.  Prolonging survival of corneal transplantation by selective sphingosine-1-phosphate receptor 1 agonist.

Authors:  Min Gao; Yong Liu; Yang Xiao; Gencheng Han; Liang Jia; Liqiang Wang; Tian Lei; Yifei Huang
Journal:  PLoS One       Date:  2014-09-12       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.